These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34322023)

  • 1. Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma.
    Yousef YA; Al Jboor M; Mohammad M; Mehyar M; Toro MD; Nazzal R; Alzureikat QH; Rejdak M; Elfalah M; Sultan I; Rejdak R; Al-Hussaini M; Al-Nawaiseh I
    Front Pharmacol; 2021; 12():696787. PubMed ID: 34322023
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma.
    Yousef YA; Noureldin AM; Sultan I; Deebajah R; Al-Hussaini M; Shawagfeh M; Mehyar M; Mohammad M; Jaradat I; AlNawaiseh I
    J Ophthalmol; 2020; 2020():8628525. PubMed ID: 32047663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma.
    Riazi-Esfahani H; Masoomian B; Khodabandeh A; Amini A; Taghizadeh S; Boujabadi L; Sharifkashani S; Shields CL; Ghassemi F
    Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1167-1175. PubMed ID: 36401651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.
    Chao A; Kao LY; Liu L; Wang NK
    BMC Ophthalmol; 2016 Mar; 16():27. PubMed ID: 26975871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short-term efficacy of intravitreal injection of melphalan for refractory vitreous seeding from retinoblastoma].
    Xue K; Ren H; Zhang R; Yuan YF; Qian J
    Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):570-574. PubMed ID: 28851196
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
    Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
    JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.
    Bogan CM; Pierce JM; Doss SD; Tao YK; Chen SC; Boyd KL; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
    Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
    Munier FL; Gaillard MC; Balmer A; Soliman S; Podilsky G; Moulin AP; Beck-Popovic M
    Br J Ophthalmol; 2012 Aug; 96(8):1078-83. PubMed ID: 22694968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of posterior sub-Tenon's carboplatin injection versus intravitreal melphalan therapy in the management of retinoblastoma with secondary vitreous seeds.
    Said AMA; Aly MG; Rashed HO; Rady AM
    Int J Ophthalmol; 2018; 11(3):445-455. PubMed ID: 29600179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients.
    Xue K; Ren H; Meng F; Zhang R; Qian J
    BMC Ophthalmol; 2019 Feb; 19(1):61. PubMed ID: 30808420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
    Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
    Rao R; Honavar SG; Sharma V; Reddy VAP
    Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal Carboplatin as Salvage Treatment for Progressive Vitreous Disease in Retinoblastoma: A Phase I Clinical Trial.
    King BA; Wilson MW; Kaluzny T; Meredith C; Overbey-Canon J; Chiang J; Brennan RC
    Ophthalmol Retina; 2023 Apr; 7(4):354-359. PubMed ID: 36372348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Group D Retinoblastoma With Resistant Vitreous Seeds After Integration of Intravitreal Chemotherapy to the Treatment Protocol.
    Amin S; Rizvi F; Zia N; Ali A; Hamid A; Kumari B
    Cureus; 2020 Nov; 12(11):e11757. PubMed ID: 33409006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal injection of melphalan for intraocular retinoblastoma.
    Suzuki S; Aihara Y; Fujiwara M; Sano S; Kaneko A
    Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular Survival Following Intravitreal Melphalan as Adjuvant Treatment for Vitreous Retinoblastoma Seeding.
    Alahmadi G; Maktabi AMY; Sesma G; Almesfer S
    Clin Ophthalmol; 2023; 17():1789-1800. PubMed ID: 37377999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
    Berry JL; Shah S; Bechtold M; Zolfaghari E; Jubran R; Kim JW
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28646513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.